[HTML][HTML] Pre-clinical study evaluating novel protein phosphatase 2A activators as therapeutics for neuroblastoma
LV Bownes, R Marayati, CH Quinn, AM Beierle… - Cancers, 2022 - mdpi.com
Simple Summary Despite significant advancements in neuroblastoma therapy, over half of
the children with high-risk neuroblastoma will suffer disease relapse. Protein phosphatase …
the children with high-risk neuroblastoma will suffer disease relapse. Protein phosphatase …
Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma
LV Bownes, R Marayati, CH Quinn, AM Beierle… - …, 2022 - search.proquest.com
Background: Protein phosphatase 2A (PP2A) functions as an inhibitor of cancer cell
proliferation, and its tumor suppressor function is attenuated in many cancers. Previous …
proliferation, and its tumor suppressor function is attenuated in many cancers. Previous …
[HTML][HTML] Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma
LV Bownes, R Marayati, CH Quinn, AM Beierle… - Cancers, 2022 - ncbi.nlm.nih.gov
Background: Protein phosphatase 2A (PP2A) functions as an inhibitor of cancer cell
proliferation, and its tumor suppressor function is attenuated in many cancers. Previous …
proliferation, and its tumor suppressor function is attenuated in many cancers. Previous …
Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma.
LV Bownes, R Marayati, CH Quinn, AM Beierle… - Cancers, 2022 - europepmc.org
Background Protein phosphatase 2A (PP2A) functions as an inhibitor of cancer cell
proliferation, and its tumor suppressor function is attenuated in many cancers. Previous …
proliferation, and its tumor suppressor function is attenuated in many cancers. Previous …
Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma
LV Bownes, R Marayati, CH Quinn, AM Beierle… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Protein phosphatase 2A (PP2A) functions as an inhibitor of cancer cell
proliferation, and its tumor suppressor function is attenuated in many cancers. Previous …
proliferation, and its tumor suppressor function is attenuated in many cancers. Previous …
Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma.
LV Bownes, R Marayati, CH Quinn, AM Beierle… - …, 2022 - search.ebscohost.com
Abstract Simple Summary: Despite significant advancements in neuroblastoma therapy,
over half of the children with high-risk neuroblastoma will suffer disease relapse. Protein …
over half of the children with high-risk neuroblastoma will suffer disease relapse. Protein …